Nymox Pharmaceutical CORP (NYMXF) SEC Filings — 2025
7 SEC filings for Nymox Pharmaceutical CORP (NYMXF) in 2025.
Filings
- Nymox Pharma Wins Lawsuit Dismissal — 6-K · Nov 7, 2025
- Nymox CEO Buys 102,844 Shares — 6-K · Oct 22, 2025
- Nymox Wins Legal Battles in US and Bahamas — 6-K · Sep 23, 2025
- NYMOX Remains Revenue-Less, Pushing R&D Amid Funding Concerns — 20-F · Jun 3, 2025
- Nymox Faces Employee Complaints Amid Legal Battles — 6-K · May 22, 2025
- Nymox Dismisses Delaware Lawsuit Against AscellaHealth — 6-K · Mar 11, 2025
- Nymox Pharma Files 6-K with Director Transaction Data — 6-K · Jan 2, 2025